Sugi Predict

Sugi Predict / Compounds / SCHEMBL7800519

SCHEMBL7800519

SCHEMBL7800519

COC(=O)c1cc2c(s1)CN(S(=O)(=O)CC(c1ccccc1)c1ccccc1)CC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.41
▸ L3MBTL1 Q9Y468 4/20 0.41
▸ HPGD P15428 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ PRMT5 O14744 3/20 0.40
▸ WDR77 Q9BQA1 3/20 0.40
▸ HDAC6 Q9UBN7 2/20 0.40
▸ RAB9A P51151 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PRSS1 P07477 1/20 0.37
▸ TMPRSS15 P98073 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ APOBEC3A P31941 1/20 0.37
▸ CASP6 P55212 1/20 0.37
▸ APOBEC3G Q9HC16 1/20 0.37
▸ GLA P06280 2/20 0.36
▸ GAA P10253 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1173997 0.88 HDAC6 (0.47) HPGDALDH1A1PRMT5WDR77HDAC6
SCHEMBL1174522 0.71 HDAC6 (0.53) KDM4EL3MBTL1HPGDALDH1A1PRMT5
SCHEMBL16395788 0.69 HDAC6 (0.49) KDM4EL3MBTL1HPGDALDH1A1PRMT5
SCHEMBL1263299 0.69 HDAC6 (0.54) HDAC6
SCHEMBL31670239 0.69 HDAC6 (0.61) KDM4EL3MBTL1HPGDALDH1A1HDAC6
SCHEMBL27147160 0.69 HDAC6 (0.48) KDM4EL3MBTL1HPGDALDH1A1PRMT5
SCHEMBL1174315 0.68 HDAC6 (0.54) L3MBTL1HPGDALDH1A1PRMT5WDR77
SCHEMBL3309479 0.68 KDM4E (0.54) KDM4EL3MBTL1HPGDALDH1A1PRMT5
SCHEMBL7799782 0.68 HDAC6 (0.79) KDM4EL3MBTL1HPGDALDH1A1HDAC6
SCHEMBL1173960 0.67 HDAC6 (0.52) HPGDALDH1A1PRMT5WDR77HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140329836-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-11-06 — — US disclosed
US-20140329836-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-11-06 — — US disclosed
US-20110046157-A1 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-02-24 — — US disclosed
US-20110046157-A1 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-02-24 — — US disclosed
WO-2010151317-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-12-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329836-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC5, HDAC1 KDM4E 903/4885L3MBTL1 2918/4885HPGD 1100/4885
US-20110046157-A1 Substituted hydroxamic acids and uses thereof HDAC6, HDAC5, HDAC1 KDM4E 903/4885L3MBTL1 2918/4885HPGD 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.